Cerner (CERN) Earning Somewhat Favorable Press Coverage, Study Finds

News headlines about Cerner (NASDAQ:CERN) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cerner earned a daily sentiment score of 0.20 on Accern’s scale. Accern also gave news coverage about the company an impact score of 47.0694599694384 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

These are some of the news articles that may have impacted Accern’s rankings:

Cerner (CERN) traded down $0.51 during trading hours on Monday, hitting $67.38. 2,514,600 shares of the company were exchanged, compared to its average volume of 2,355,209. The company has a debt-to-equity ratio of 0.11, a current ratio of 2.77 and a quick ratio of 2.75. The company has a market cap of $22,230.00, a PE ratio of 33.52, a PEG ratio of 2.20 and a beta of 0.94. Cerner has a 52 week low of $47.09 and a 52 week high of $73.86.

Cerner (NASDAQ:CERN) last posted its quarterly earnings results on Thursday, October 26th. The company reported $0.61 EPS for the quarter, missing analysts’ consensus estimates of $0.62 by ($0.01). The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.29 billion. Cerner had a return on equity of 15.96% and a net margin of 13.90%. The company’s revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period last year, the firm posted $0.59 EPS. sell-side analysts anticipate that Cerner will post 2.24 EPS for the current year.

CERN has been the topic of several recent analyst reports. Canaccord Genuity reissued a “buy” rating and set a $69.00 target price on shares of Cerner in a research report on Wednesday, September 6th. JPMorgan Chase & Co. cut shares of Cerner from an “overweight” rating to a “neutral” rating in a research report on Friday, October 27th. Stifel Nicolaus reissued a “hold” rating on shares of Cerner in a research report on Wednesday, November 22nd. Piper Jaffray Companies reissued a “buy” rating and set a $77.00 target price on shares of Cerner in a research report on Thursday, October 12th. Finally, Royal Bank of Canada reissued a “buy” rating on shares of Cerner in a research report on Wednesday, October 25th. One equities research analyst has rated the stock with a sell rating, fourteen have given a hold rating and nine have given a buy rating to the company. Cerner has an average rating of “Hold” and a consensus target price of $69.50.

In related news, President Zane M. Burke sold 50,000 shares of Cerner stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $70.00, for a total value of $3,500,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Michael R. Battaglioli sold 4,000 shares of Cerner stock in a transaction that occurred on Wednesday, December 13th. The shares were sold at an average price of $69.89, for a total transaction of $279,560.00. Following the completion of the transaction, the vice president now owns 4,000 shares of the company’s stock, valued at $279,560. The disclosure for this sale can be found here. Insiders sold a total of 788,000 shares of company stock valued at $52,190,800 over the last quarter. 13.11% of the stock is owned by company insiders.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.com-unik.info/2017/12/25/cerner-cern-earning-somewhat-favorable-press-coverage-study-finds.html.

Cerner Company Profile

Cerner Corporation (Cerner) is a supplier of healthcare information technology (HCIT). The Company offers a range of intelligent solutions and services that support the clinical, financial and operational needs of organizations of all sizes. The Company’s segments include Domestic and Global. The Domestic segment includes revenue contributions and expenditures associated with business activity in the United States.

Insider Buying and Selling by Quarter for Cerner (NASDAQ:CERN)

Receive News & Ratings for Cerner Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cerner and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit